Evaluation of Xuesaitong in the Adjuvant Treatment of Non-biliary Mild Acute Pancreatitis
YU Yanhui
Abstract：Objective? To investigate the clinical effect of somatostatin combined with Xuesaitong in the treatment of mild non-biliary mild acute pancreatitis. Methods Fifty-five patients with mild non-biliary pancreatitis admitted to our hospital from October 2017 to July 2018 were divided into observation group (27 cases) and control group (28 cases) according to the different therapeutic drugs. The observation group was given somatostatin combined with Xuesaitong, and the control group was given single somatostatin. The clinical effect was compared between two groups. Results After One week treatment, the total effective rate was 92.59% in the observation group and 89.29% in the control group (χ2=0.002, P>0.05). All the laboratory indexes and APACHE II scores after one week treatment were significantly improved than before treatment (P<0.05), but there was no significant difference between the two groups (P>0.05). There was no significant difference in the incidence of adverse reactions between the two groups during treatment (P>0.05). No serious complications occurred in the two groups. vement index were significantly higher than normal acupuncture group (P<0.05). Conclusion Somatostatin combined with Xuesaitong is safe and effective in the treatment of mild non-biliary pancreatitis, and is worth popularizing.
Keywords：PancreatitisAcuteMildNon-biliarySomatostatinXuesaitong
Publication Date：2019-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 57-59 )